Oppenheimer Initiates Coverage on Quince Therapeutics (NASDAQ:QNCX)
Oppenheimer started coverage on shares of Quince Therapeutics (NASDAQ:QNCX – Free Report) in a report released on Monday, Marketbeat.com reports. The brokerage issued an outperform rating and a $10.00 price target on the stock. Several other analysts have also recently issued reports on QNCX. Brookline Capital Management initiated coverage on Quince Therapeutics in a research […]
Oppenheimer started coverage on shares of Quince Therapeutics (NASDAQ:QNCX – Free Report) in a report released on Monday, Marketbeat.com reports. The brokerage issued an outperform rating and a $10.00 price target on the stock. Several other analysts have also recently issued reports on QNCX. Brookline Capital Management initiated coverage on Quince Therapeutics in a research […]
